Literature DB >> 23519095

Is Tako-tsubo syndrome in the postpartum period a clinical entity different from peripartum cardiomyopathy?

Rodolfo Citro1, Roberta Giudice, Marco Mirra, Raffaele Petta, Cesare Baldi, Eduardo Bossone, Federico Piscione.   

Abstract

AIMS: To conduct a systematic review of case reports about Tako-tsubo syndrome (TTS) after delivery in order to assess whether TTS in the postpartum period is a peculiar entity or only a variant form of peripartum cardiomyopathy.
METHODS: We performed a systematic literature search on the occurrence of TTS after Cesarean section or spontaneous delivery using the scientific literature databases Medline, EMBASE and the Cochrane library. We selected 14 case reports in English. Primary/elective cesarean section or spontaneous delivery; absence of preexisting cardiovascular disease or fetal malformations; identification of diagnostic criteria for TTS; onset of TTS symptoms after delivery were the inclusion criteria.
RESULTS: Fifteen cases were selected. Cesarean section 24 h before the onset of TTS was reported in 13. All patients presented dyspnea or chest pain. The majority had mild troponin elevation, non-ST-segment elevation. Apical ballooning was observed in 60% of cases, midventricular ballooning in 33%, basal ballooning in 7%. Although 13 patients experienced acute cardiac complications (pulmonary edema, cardiogenic shock, cardiac arrest), in all left ventricular systolic function normalized within 13.43 ± 10.96 days.
CONCLUSION: Women in the postpartum period, notably after Cesarean delivery, may represent another new vulnerable group at increased risk for TTS. TTS in the postpartum period should be considered a clinical entity different from peripartum cardiomyopathy with specific clinical, therapeutic and prognostic implications.

Entities:  

Mesh:

Year:  2013        PMID: 23519095     DOI: 10.2459/JCM.0b013e32835f1a49

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  7 in total

Review 1.  The role of multimodality imaging in takotsubo cardiomyopathy.

Authors:  Osamu Manabe; Masanao Naya; Noriko Oyama-Manabe; Kazuhiro Koyanagawa; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2018-06-01       Impact factor: 5.952

2.  Takotsubo syndrome-associated ventricular standstill in a peripartum patient: case report and review of the literature.

Authors:  Nelson Lee; Kevin Wade Lee; Matthew Michael D'Ambrosio; Joseph Vaughan Banta; Apostolos Voudouris; Antonios Tsompanidis
Journal:  Clin Case Rep       Date:  2017-12-22

3.  Subsequent Safe Pregnancy with Cesarean Delivery in a Patient with a History of Peripartum Takotsubo Syndrome Complicated by Cardiogenic Shock.

Authors:  Rodolfo Citro; Michele Bellino; Flora Minichino; Davide Di Vece; Donatella Ferraioli; Raffaele Petta
Journal:  J Cardiovasc Echogr       Date:  2017 Jul-Sep

Review 4.  Peripartum cardiomyopathy: disease or syndrome?

Authors:  Lucia Baris; Jérôme Cornette; Mark R Johnson; Karen Sliwa; Jolien W Roos-Hesselink
Journal:  Heart       Date:  2019-02-12       Impact factor: 5.994

5.  Inverted Takotsubo Syndrome With HELLP Syndrome: A Case Report.

Authors:  Paul Gabarre; Pablo Ruiz; Camille Chenevier-Gobeaux; Etienne Charpentier; Laurie Soulat-Dufour; Ariel Cohen; Laurence Monnier-Cholley; Lotfi Chemali; Hélène François; Mathieu Kerneis; Guillaume Lefèvre; Mathieu Boissan
Journal:  Front Cardiovasc Med       Date:  2022-03-31

6.  Inverted stress- induced cardiomyopathy as a unusual variant of acute heart failure after cesarean delivery- a case report.

Authors:  Anna Ledakowicz-Polak; Jarosław Bartodziej; Agata Majos; Marzenna Zielińska
Journal:  BMC Cardiovasc Disord       Date:  2016-04-29       Impact factor: 2.298

7.  Clinical characteristics and long-term outcomes of peripartum takotsubo cardiomyopathy and peripartum cardiomyopathy.

Authors:  Dong-Yeon Kim; So Ree Kim; Sung-Ji Park; Jeong-Hun Seo; Eun Kyoung Kim; Jeong Hoon Yang; Sung-A Chang; Jin-Oh Choi; Sang-Chol Lee; Seung Woo Park
Journal:  ESC Heart Fail       Date:  2020-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.